Alexander J. Bankovich
0000-0003-2368-4479
Publication & Citation Trends
Publications
0 total
Abstract 6308: Preclinical development of ABBV-319: a CD19-targeting glucocorticoid receptor modulator (GRM) agonist antibody-drug conjugate (ADC) for the treatment of B-cell malignancies
Cited by 0
Semantic Scholar
ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors OA
Cited by 42
Semantic Scholar
Genomic analysis and prediction of therapeutic vulnerabilities of small cell lung cancer from rovalpituzumab tesirine phase III trial (MERU).
Cited by 0
Semantic Scholar
Abstract NT-113: SC-003, AN ANTIBODY-DRUG CONJUGATE TARGETING DIPEPTIDASE 3, EXHIBITS POTENT ANTI-TUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF HIGH GRADE SEROUS OVARIAN CANCER
Cited by 2
Semantic Scholar
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Cited by 145
Semantic Scholar
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer. OA
Cited by 91
Semantic Scholar
A DLL3-targeted theranostic for small cell lung cancer: Imaging a low density target with a site-specifically modified radioimmunoconjugate.
Cited by 3
Semantic Scholar
Abstract 1220: A novel PTK7-targeted antibody-drug conjugate eliminates tumor-initiating cells and induces sustained tumor regressions
Cited by 0
Semantic Scholar
Conjugués médicament-anticorps anti-ptk7
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Research Studies
(27)
Monoclonal and Polyclonal Antibodies Research
(18)
Protein Degradation and Inhibitors
(17)
Peptidase Inhibition and Analysis
(16)
T-cell and B-cell Immunology
(12)
Affiliations
Scripps Research Institute
Howard Hughes Medical Institute
Bristol-Myers Squibb (Germany)
University of Illinois Urbana-Champaign
University of California, San Francisco